NAXBYIN Trademark

Trademark Overview

On Wednesday, January 18, 2017, a trademark application was filed for NAXBYIN with the United States Patent and Trademark Office. The USPTO has given the NAXBYIN trademark a serial number of 87305559. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 31, 2020. This trademark is owned by Amphastar Pharmaceuticals, Inc.. The NAXBYIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics
naxbyin

General Information

Serial Number87305559
Word MarkNAXBYIN
Filing DateWednesday, January 18, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 31, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmphastar Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730
Party NameAmphastar Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRancho Cucamonga, CA 91730

Trademark Events

Event DateEvent Description
Monday, August 31, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 31, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2019EXTENSION 5 GRANTED
Friday, November 22, 2019EXTENSION 5 FILED
Monday, December 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 22, 2019TEAS EXTENSION RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2019EXTENSION 4 GRANTED
Monday, June 17, 2019EXTENSION 4 FILED
Monday, June 17, 2019TEAS EXTENSION RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019EXTENSION 3 GRANTED
Monday, January 7, 2019EXTENSION 3 FILED
Monday, January 7, 2019TEAS EXTENSION RECEIVED
Monday, January 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 2, 2018EXTENSION 2 GRANTED
Monday, July 2, 2018EXTENSION 2 FILED
Monday, July 2, 2018TEAS EXTENSION RECEIVED
Friday, January 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 17, 2018EXTENSION 1 GRANTED
Wednesday, January 17, 2018EXTENSION 1 FILED
Wednesday, January 17, 2018TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 26, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 17, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 17, 2017EXAMINER'S AMENDMENT ENTERED
Monday, April 17, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 17, 2017EXAMINERS AMENDMENT E-MAILED
Monday, April 17, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, April 13, 2017ASSIGNED TO EXAMINER
Thursday, February 23, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, February 7, 2017ASSIGNED TO LIE
Tuesday, January 24, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, January 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 21, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

naxbyin preparations pharmaceutical treatment overdose depression addiction opioid including drug synthetic